IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,856 | -59.4% | 51,018 | -56.1% | 0.00% | – |
| Q3 2022 | $44,000 | -42.9% | 116,320 | -30.6% | 0.00% | – |
| Q2 2022 | $77,000 | +208.0% | 167,693 | +228.6% | 0.00% | – |
| Q1 2022 | $25,000 | -85.1% | 51,026 | -82.7% | 0.00% | – |
| Q4 2021 | $168,000 | -19.6% | 295,018 | +45.2% | 0.00% | – |
| Q3 2021 | $209,000 | -40.1% | 203,196 | -30.0% | 0.00% | – |
| Q2 2021 | $349,000 | -45.7% | 290,258 | -41.3% | 0.00% | – |
| Q1 2021 | $643,000 | +173.6% | 494,585 | +669.7% | 0.00% | – |
| Q4 2020 | $235,000 | +591.2% | 64,258 | +303.1% | 0.00% | – |
| Q3 2020 | $34,000 | +112.5% | 15,942 | +34.3% | 0.00% | – |
| Q1 2020 | $16,000 | -81.0% | 11,871 | -60.6% | 0.00% | – |
| Q4 2018 | $84,000 | – | 30,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
| Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
| Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
| MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
| WADE G W & INC | 35,000 | $42,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
| BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |